BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21602901)

  • 1. Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America.
    Palma J; Sasso DF; Dufort G; Koop K; Sampor C; Diez B; Richard L; Castillo L; Chantada GL
    Bone Marrow Transplant; 2012 Apr; 47(4):522-7. PubMed ID: 21602901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma.
    Kremens B; Wieland R; Reinhard H; Neubert D; Beck JD; Klingebiel T; Bornfeld N; Havers W
    Bone Marrow Transplant; 2003 Feb; 31(4):281-4. PubMed ID: 12621463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement.
    Matsubara H; Makimoto A; Higa T; Kawamoto H; Sakiyama S; Hosono A; Takayama J; Takaue Y; Murayama S; Sumi M; Kaneko A; Ohira M
    Bone Marrow Transplant; 2005 Apr; 35(8):763-6. PubMed ID: 15750608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
    Kremens B; Gruhn B; Klingebiel T; Hasan C; Laws HJ; Koscielniak E; Hero B; Selle B; Niemeyer C; Finckenstein FG; Schulz A; Wawer A; Zintl F; Graf N
    Bone Marrow Transplant; 2002 Dec; 30(12):893-8. PubMed ID: 12476282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
    Dunkel IJ; Khakoo Y; Kernan NA; Gershon T; Gilheeney S; Lyden DC; Wolden SL; Orjuela M; Gardner SL; Abramson DH
    Pediatr Blood Cancer; 2010 Jul; 55(1):55-9. PubMed ID: 20486171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma.
    Dunkel IJ; Chan HS; Jubran R; Chantada GL; Goldman S; Chintagumpala M; Khakoo Y; Abramson DH
    Pediatr Blood Cancer; 2010 Jul; 55(1):149-52. PubMed ID: 20486181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
    Modak S; Gardner S; Dunkel IJ; Balmaceda C; Rosenblum MK; Miller DC; Halpern S; Finlay JL
    J Clin Oncol; 2004 May; 22(10):1934-43. PubMed ID: 15143087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas.
    Gururangan S; McLaughlin C; Quinn J; Rich J; Reardon D; Halperin EC; Herndon J; Fuchs H; George T; Provenzale J; Watral M; McLendon RE; Friedman A; Friedman HS; Kurtzberg J; Vredenbergh J; Martin PL
    J Clin Oncol; 2003 Jun; 21(11):2187-91. PubMed ID: 12775745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation.
    Demirer T; Uysal VA; Ayli M; Genc Y; Ilhan O; Koc H; Dagli M; Arat M; Gunel N; Fen T; Dincer S; Ustael N; Yildiz M; Ustun T; Seyrek E; Ozet G; Muftuoglu O; Akan H
    Bone Marrow Transplant; 2003 May; 31(9):755-61. PubMed ID: 12732881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
    Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
    Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
    Dunkel IJ; Jubran RF; Gururangan S; Chantada GL; Finlay JL; Goldman S; Khakoo Y; O'Brien JM; Orjuela M; Rodriguez-Galindo C; Souweidane MM; Abramson DH
    Pediatr Blood Cancer; 2010 Mar; 54(3):384-7. PubMed ID: 19908299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
    Al-Faris N; Al Harbi T; Goia C; Pappo A; Doyle J; Gassas A
    Pediatr Blood Cancer; 2007 Aug; 49(2):190-5. PubMed ID: 17262797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilized peripheral blood progenitor cells (PBPC) in support of tandem cycles of high-dose chemotherapy (HDC).
    Meisenberg BR; Miller WE; McMillan R
    Bone Marrow Transplant; 1996 Dec; 18(6):1087-93. PubMed ID: 8971377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
    Kleiner S; Kirsch A; Schwaner I; Kingreen D; Schwella N; Huhn D; Siegert W
    Bone Marrow Transplant; 1997 Dec; 20(11):953-9. PubMed ID: 9422474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma.
    Fontelonga A; Kelly AJ; MacKintosh FR; Hall S; Monroe P; Wilson GS; Shaft D; Ruthven A; Ascensao JL
    Bone Marrow Transplant; 1997 May; 19(10):983-8. PubMed ID: 9169642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital.
    Campbell AD; Cohn SL; Reynolds M; Seshadri R; Morgan E; Geissler G; Rademaker A; Marymount M; Kalapurakal J; Haut PR; Duerst R; Kletzel M
    J Clin Oncol; 2004 Jul; 22(14):2885-90. PubMed ID: 15254057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma.
    Sauerbrey A; Bielack S; Kempf-Bielack B; Zoubek A; Paulussen M; Zintl F
    Bone Marrow Transplant; 2001 May; 27(9):933-7. PubMed ID: 11436103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children with high grade osteosarcoma.
    Miniero R; Brach del Prever A; Vassallo E; Nesi F; Busca A; Fagioli F; Albiani R; Picci P; Bacci G; Madon E
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S37-40. PubMed ID: 9989888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.